Shigeru Imoto
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
-
- Breast Lesions and Carcinomas
Papers in
-
- Breast Cancer Treatment Studies 63
- Oncology 61
- HER2/EGFR in Cancer Research 21
- Cancer Treatment and Pharmacology 12
- Cancer survivorship and care 11
- Co-authors
- Takahiro Hasebe (32 shared papers)Yosuke Uchitomi (22 shared papers)Noriaki Wada (25 shared papers)Tatsuo Akechi (13 shared papers)Atsushi Ochiai (16 shared papers)Masatoshi Inagaki (14 shared papers)Tomohito Nakano (9 shared papers)Yutaka Matsuoka (16 shared papers)
- Journals
- Japanese Journal of Clinical Oncology (12 papers)Breast Cancer (10 papers)Journal of Clinical Oncology (8 papers)Breast Cancer Research and Treatment (6 papers)Human Pathology (4 papers)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Shigeru Imoto
110 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 864
- Pathology and Forensic Medicine 759
- Oncology 1.1k
- Genetics 356
- Dermatology 255
Countries citing papers authored by Shigeru Imoto
This map shows the geographic impact of Shigeru Imoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Imoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Imoto more than expected).
Fields of papers citing papers by Shigeru Imoto
This network shows the impact of papers produced by Shigeru Imoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Imoto. The network helps show where Shigeru Imoto may publish in the future.
Co-authors
The 25 scholars most cited alongside Shigeru Imoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 263 | |
| 2 | 2000 | 174 | |
| 3 | 1997 | 149 | |
| 4 | 2002 | 102 | |
| 5 | 2001 | 86 | |
| 6 | 2014 | 75 | |
| 7 | 2015 | 66 | |
| 8 | 2001 | 62 | |
| 9 | 1997 | 59 | |
| 10 | 2007 | 58 | |
| 11 | 2002 | 57 | |
| 12 | 1996 | 57 | |
| 13 | 2005 | 48 | |
| 14 | 2005 | 45 | |
| 15 | 1999 | 44 | |
| 16 | 2002 | 44 | |
| 17 | 2005 | 43 | |
| 18 | Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast. | 1999 | 42 |
| 19 | 2008 | 39 | |
| 20 | 2005 | 37 |
About Shigeru Imoto
Shigeru Imoto is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Surgery, having authored 114 papers that have together received 2.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (63 papers), Breast Lesions and Carcinomas (41 papers), HER2/EGFR in Cancer Research (21 papers), Cancer-related cognitive impairment studies (13 papers), Breast Implant and Reconstruction (13 papers), Cancer Treatment and Pharmacology (12 papers), Estrogen and related hormone effects (12 papers) and Cancer survivorship and care (11 papers). The work is most often cited by research in Cancer Research (864 citations), Pathology and Forensic Medicine (759 citations), Oncology (1.1k citations), Genetics (356 citations) and Dermatology (255 citations). Shigeru Imoto has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Takahiro Hasebe, Yosuke Uchitomi, Noriaki Wada, Tatsuo Akechi, Atsushi Ochiai, Masatoshi Inagaki, Tomohito Nakano, Yutaka Matsuoka, Koji Murakami and Satoshi Sasaki. Their work appears in journals such as Japanese Journal of Clinical Oncology, Breast Cancer, Journal of Clinical Oncology, Breast Cancer Research and Treatment and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.